Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Assets
Cash and cash equivalents	$ 1,143,317	$ 1,980,015
Inventory		22,666
Receivables	6,727
Advance to related party		58,135
Prepaid expense and other current assets	46,174	23,635
Total current assets	1,196,218	2,084,451
Goodwill	133,449
Patents, net	168,417	182,386
Property and equipment, net	18,997	26,997
Total assets	1,517,081	2,293,834
Liabilities and Stockholders' Deficit
Accounts payable and accrued expenses	137,761	159,300
Advances from investors	56,225	777,258
Convertible notes payable – related party	513,356	886,481
Total current liabilities	707,342	1,823,039
Total liabilities	707,342	1,823,039
Commitments and contingencies
Stockholders' equity
Preferred stock, $0.01 par value: Authorized shares - 10,000,000, Issued and outstanding shares – 0 at September 30, 2018 and December 31, 2017
Common stock, $0.01 par value: Authorized shares - 100,000,000,Issued and outstanding shares – 37,299,276 and 23,156,563 at September 30, 2018 and December 31, 2017, respectively	372,993	231,565
Additional paid-in capital	3,139,033	2,123,205
Accumulated deficit	(2,702,287)	(1,883,975)
Total stockholders’ equity	809,739	470,795
Total liabilities and stockholders’ equity	$ 1,517,081	$ 2,293,834